Mylan Gives Up Exclusivity For US Kaletra Rival

As AbbVie Stays Quiet Over Global IP Waiver

 
• By Dave Wallace
  
Waiver
Mylan has waived exclusivity rights for its generic Kaletra • Source: Shutterstock

More from Generics

More from Products